{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:14Z","timestamp":1790140334346,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020544","name":"CT Brain Tumor Alliance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020544","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Surgical resection has long been the treatment of choice for meningiomas and is considered curative in many cases. Indeed, the extent of resection (EOR) remains a significant factor in determining disease recurrence and outcome optimization for patients undergoing surgery. Although the Simpson Grading Scale continues to be widely accepted as the measure of EOR and is used to predict symptomatic recurrence, its utility is under increasing scrutiny. The influence of surgery in the definitive management of meningioma is being re-appraised considering the rapid evolution of our understanding of the biology of meningioma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Although historically considered \u201cbenign\u201d lesions, meningioma natural history can vary greatly, behaving with unexpectedly high recurrence rates and growth which do not always behave in accordance with their WHO grade. Histologically confirmed WHO grade 1 tumors may demonstrate unexpected recurrence, malignant transformation, and aggressive behavior, underscoring the molecular complexity and heterogeneity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>As our understanding of the clinical predictive power of genomic and epigenomic factors matures, we here discuss the importance of surgical decision-making paradigms in the context of our rapidly evolving understanding of these molecular features.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-023-04272-z","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:03:00Z","timestamp":1680530580000},"page":"253-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Surgical strategies for intracranial meningioma in the molecular era"],"prefix":"10.1007","volume":"162","author":[{"given":"Alper","family":"Dincer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul F.","family":"Morales-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Tabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanat","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Fulbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Erson-Omay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"4272_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro-Oncology 22:iv1\u2013iv96. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","DOI":"10.1093\/neuonc\/noaa200"},{"key":"4272_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11060-021-03832-5","volume":"154","author":"H Ahmeti","year":"2021","unstructured":"Ahmeti H, Borzikowsky C, Hollander D et al (2021) Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients. J Neurooncol 154:335\u2013344. https:\/\/doi.org\/10.1007\/s11060-021-03832-5","journal-title":"J Neurooncol"},{"key":"4272_CR3","doi-asserted-by":"publisher","first-page":"706481","DOI":"10.1155\/2013\/706481","volume":"2013","author":"K Violaris","year":"2013","unstructured":"Violaris K, Katsarides V, Karakyriou M, Sakellariou P (2013) Surgical outcome of treating grades II and III meningiomas: a report of 32 cases. Neurosci J 2013:706481. https:\/\/doi.org\/10.1155\/2013\/706481","journal-title":"Neurosci J"},{"key":"4272_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s007010050398","volume":"141","author":"J Ayerbe","year":"1999","unstructured":"Ayerbe J, Lobato RD, de la Cruz J et al (1999) Risk factors predicting recurrence in patients operated on for intracranial meningioma. a multivariate analysis. Acta Neurochir (Wien) 141:921\u2013932. https:\/\/doi.org\/10.1007\/s007010050398","journal-title":"Acta Neurochir (Wien)"},{"key":"4272_CR5","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.1038\/s41598-020-68177-x","volume":"10","author":"MV Corniola","year":"2020","unstructured":"Corniola MV, Lem\u00e9e J-M, Meling TR (2020) Histological transformation in recurrent WHO grade I meningiomas. Sci Rep 10:11220. https:\/\/doi.org\/10.1038\/s41598-020-68177-x","journal-title":"Sci Rep"},{"key":"4272_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-021-03874-9","volume":"156","author":"SM Robert","year":"2022","unstructured":"Robert SM, Vetsa S, Nadar A et al (2022) The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications. J Neurooncol 156:205\u2013214. https:\/\/doi.org\/10.1007\/s11060-021-03874-9","journal-title":"J Neurooncol"},{"key":"4272_CR7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/cancers14082007","volume":"14","author":"S Chotai","year":"2022","unstructured":"Chotai S, Schwartz TH (2022) The Simpson Grading: is it still valid? Cancers (Basel) 14:2007. https:\/\/doi.org\/10.3390\/cancers14082007","journal-title":"Cancers (Basel)"},{"key":"4272_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.6.JNS201904","volume":"1","author":"TH Schwartz","year":"2020","unstructured":"Schwartz TH, McDermott MW (2020) The Simpson grade: abandon the scale but preserve the message. J Neurosurg 1:1\u20138. https:\/\/doi.org\/10.3171\/2020.6.JNS201904","journal-title":"J Neurosurg"},{"key":"4272_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3171\/2019.8.JNS191266","volume":"133","author":"MW Youngblood","year":"2019","unstructured":"Youngblood MW, Duran D, Montejo JD et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg 133:1345\u20131354. https:\/\/doi.org\/10.3171\/2019.8.JNS191266","journal-title":"J Neurosurg"},{"key":"4272_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","volume":"23","author":"MW Youngblood","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L et al (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro-Oncology 23:783\u2013794. https:\/\/doi.org\/10.1093\/neuonc\/noaa226","journal-title":"Neuro-Oncology"},{"key":"4272_CR11","doi-asserted-by":"publisher","DOI":"10.3171\/2020.7.JNS201042","author":"TP Gupte","year":"2020","unstructured":"Gupte TP, Li C, Jin L et al (2020) Clinical and genomic factors associated with seizures in meningiomas. J Neurosurg. https:\/\/doi.org\/10.3171\/2020.7.JNS201042","journal-title":"J Neurosurg"},{"key":"4272_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncology"},{"key":"4272_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.surneu.2004.07.049","volume":"63","author":"H Eskandary","year":"2005","unstructured":"Eskandary H, Sabba M, Khajehpour F, Eskandari M (2005) Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol 63:550\u2013553. https:\/\/doi.org\/10.1016\/j.surneu.2004.07.049","journal-title":"Surg Neurol"},{"key":"4272_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-019-03104-3","volume":"142","author":"AI Islim","year":"2019","unstructured":"Islim AI, Mohan M, Moon RDC et al (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 142:211\u2013221. https:\/\/doi.org\/10.1007\/s11060-019-03104-3","journal-title":"J Neurooncol"},{"key":"4272_CR15","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","volume":"357","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW, Ikram MA, Tanghe HL et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821\u20131828. https:\/\/doi.org\/10.1056\/NEJMoa070972","journal-title":"N Engl J Med"},{"key":"4272_CR16","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.3171\/2011.9.FOCUS11220","volume":"31","author":"R Chamoun","year":"2011","unstructured":"Chamoun R, Krisht KM, Couldwell WT (2011) Incidental meningiomas. Neurosurg Focus 31:E19. https:\/\/doi.org\/10.3171\/2011.9.FOCUS11220","journal-title":"Neurosurg Focus"},{"key":"4272_CR17","doi-asserted-by":"publisher","first-page":"e0151080","DOI":"10.1371\/journal.pone.0151080","volume":"11","author":"AK H\u00e5berg","year":"2016","unstructured":"H\u00e5berg AK, Hammer TA, Kvistad KA et al (2016) Incidental intracranial findings and their clinical impact; the HUNT MRI Study in a general population of 1006 participants between 50\u201366 years. PLoS ONE 11:e0151080. https:\/\/doi.org\/10.1371\/journal.pone.0151080","journal-title":"PLoS ONE"},{"key":"4272_CR18","doi-asserted-by":"publisher","DOI":"10.3171\/2017.12.JNS171943","author":"KH Kim","year":"2018","unstructured":"Kim KH, Kang SJ, Choi J-W et al (2018) Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. J Neurosurg. https:\/\/doi.org\/10.3171\/2017.12.JNS171943","journal-title":"J Neurosurg"},{"key":"4272_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","volume":"105","author":"S Yano","year":"2006","unstructured":"Yano S, Kuratsu J (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105:538\u2013543. https:\/\/doi.org\/10.3171\/jns.2006.105.4.538","journal-title":"J Neurosurg"},{"key":"4272_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/02688697.2017.1297765","volume":"31","author":"MH Mohammad","year":"2017","unstructured":"Mohammad MH, Chavredakis E, Zakaria R et al (2017) A national survey of the management of patients with incidental meningioma in the United Kingdom. Br J Neurosurg 31:459\u2013463. https:\/\/doi.org\/10.1080\/02688697.2017.1297765","journal-title":"Br J Neurosurg"},{"key":"4272_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/2152-7806.112617","volume":"4","author":"RH Wong","year":"2013","unstructured":"Wong RH, Wong AK, Vick N, Farhat HI (2013) Natural history of multiple meningiomas. Surg Neurol Int 4:71. https:\/\/doi.org\/10.4103\/2152-7806.112617","journal-title":"Surg Neurol Int"},{"key":"4272_CR22","first-page":"49","volume":"19","author":"JL Drape","year":"1992","unstructured":"Drape JL, Krause D, Tongio J (1992) MRI of aggressive meningiomas. J Neuroradiol 19:49\u201362","journal-title":"J Neuroradiol"},{"key":"4272_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s13244-013-0302-4","volume":"5","author":"J Watts","year":"2014","unstructured":"Watts J, Box G, Galvin A et al (2014) Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging 5:113\u2013122. https:\/\/doi.org\/10.1007\/s13244-013-0302-4","journal-title":"Insights Imaging"},{"key":"4272_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22\u201339. https:\/\/doi.org\/10.1136\/jnnp.20.1.22","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4272_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Mirimanoff","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM et al (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18\u201324. https:\/\/doi.org\/10.3171\/jns.1985.62.1.0018","journal-title":"J Neurosurg"},{"key":"4272_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3171\/jns.1983.58.1.0051","volume":"58","author":"AB Adegbite","year":"1983","unstructured":"Adegbite AB, Khan MI, Paine KW, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51\u201356. https:\/\/doi.org\/10.3171\/jns.1983.58.1.0051","journal-title":"J Neurosurg"},{"key":"4272_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3171\/2012.6.JNS111987","volume":"117","author":"S Qi","year":"2012","unstructured":"Qi S, Liu Y, Pan J et al (2012) A radiopathological classification of dural tail sign of meningiomas: laboratory investigation. J Neurosurg 117:645\u2013653. https:\/\/doi.org\/10.3171\/2012.6.JNS111987","journal-title":"J Neurosurg"},{"key":"4272_CR28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L","volume":"89","author":"F Yamasaki","year":"2000","unstructured":"Yamasaki F, Yoshioka H, Hama S et al (2000) Recurrence of meningiomas. Cancer 89:1102\u20131110. https:\/\/doi.org\/10.1002\/1097-0142(20000901)89:5%3c1102::AID-CNCR20%3e3.0.CO;2-L","journal-title":"Cancer"},{"key":"4272_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4272_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF01405788","volume":"107","author":"M Naumann","year":"1990","unstructured":"Naumann M, Meixensberger J (1990) Factors influencing meningioma recurrence rate. Acta neurochir 107:108\u2013111. https:\/\/doi.org\/10.1007\/BF01405788","journal-title":"Acta neurochir"},{"key":"4272_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11060-017-2481-1","volume":"133","author":"KM Vo\u00df","year":"2017","unstructured":"Vo\u00df KM, Spille DC, Sauerland C et al (2017) The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? J Neurooncol 133:641\u2013651. https:\/\/doi.org\/10.1007\/s11060-017-2481-1","journal-title":"J Neurooncol"},{"key":"4272_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3171\/2015.7.JNS15546","volume":"125","author":"A Mansouri","year":"2016","unstructured":"Mansouri A, Klironomos G, Taslimi S et al (2016) Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non\u2013skull base meningiomas. J Neurosurg 125:431\u2013440. https:\/\/doi.org\/10.3171\/2015.7.JNS15546","journal-title":"J Neurosurg"},{"key":"4272_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"4272_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/neuros\/nyx312","volume":"82","author":"MO Chohan","year":"2018","unstructured":"Chohan MO, Ryan CT, Singh R et al (2018) Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology. Neurosurgery 82:824\u2013832. https:\/\/doi.org\/10.1093\/neuros\/nyx312","journal-title":"Neurosurgery"},{"key":"4272_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/neuonc\/nov177","volume":"18","author":"AA Aizer","year":"2016","unstructured":"Aizer AA, Abedalthagafi M, Bi WL et al (2016) A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro-Oncology 18:269\u2013274. https:\/\/doi.org\/10.1093\/neuonc\/nov177","journal-title":"Neuro-Oncology"},{"key":"4272_CR36","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1002\/cncr.29639","volume":"121","author":"AA Aizer","year":"2015","unstructured":"Aizer AA, Bi WL, Kandola MS et al (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121:4376\u20134381. https:\/\/doi.org\/10.1002\/cncr.29639","journal-title":"Cancer"},{"key":"4272_CR37","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1007\/s00330-018-5830-3","volume":"29","author":"YW Park","year":"2019","unstructured":"Park YW, Oh J, You SC et al (2019) Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging. Eur Radiol 29:4068\u20134076. https:\/\/doi.org\/10.1007\/s00330-018-5830-3","journal-title":"Eur Radiol"},{"key":"4272_CR38","doi-asserted-by":"publisher","first-page":"879528","DOI":"10.3389\/fonc.2022.879528","volume":"12","author":"S Sun","year":"2022","unstructured":"Sun S, Ren L, Miao Z et al (2022) Application of MRI-based radiomics in preoperative prediction of NF2 alteration in intracranial meningiomas. Front Oncol 12:879528. https:\/\/doi.org\/10.3389\/fonc.2022.879528","journal-title":"Front Oncol"},{"key":"4272_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40478-022-01377-w","volume":"10","author":"Y Teranishi","year":"2022","unstructured":"Teranishi Y, Okano A, Miyawaki S et al (2022) Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index. Acta Neuropathol Commun 10:76. https:\/\/doi.org\/10.1186\/s40478-022-01377-w","journal-title":"Acta Neuropathol Commun"},{"key":"4272_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289. https:\/\/doi.org\/10.1038\/ng.2526","journal-title":"Nat Genet"},{"key":"4272_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11060-021-03819-2","volume":"154","author":"L Jin","year":"2021","unstructured":"Jin L, Youngblood MW, Gupte TP et al (2021) Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas. J Neurooncol 154:237\u2013246. https:\/\/doi.org\/10.1007\/s11060-021-03819-2","journal-title":"J Neurooncol"},{"key":"4272_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D et al (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"key":"4272_CR43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O et al (2021) Loss of H3K27me3 in meningiomas. Neuro-Oncology 23:1282\u20131291. https:\/\/doi.org\/10.1093\/neuonc\/noab036","journal-title":"Neuro-Oncology"},{"key":"4272_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649\u2013659. https:\/\/doi.org\/10.1038\/s41588-022-01061-8","journal-title":"Nat Genet"},{"key":"4272_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv377","journal-title":"J Natl Cancer Inst"},{"key":"4272_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11060-019-03333-6","volume":"145","author":"A Guyot","year":"2019","unstructured":"Guyot A, Duchesne M, Robert S et al (2019) Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma. J Neurooncol 145:449\u2013459. https:\/\/doi.org\/10.1007\/s11060-019-03333-6","journal-title":"J Neurooncol"},{"key":"4272_CR47","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte G, Peyre M, Pouget C et al (2020) Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study. J Neuropathol Exp Neurol 79:754\u2013762. https:\/\/doi.org\/10.1093\/jnen\/nlaa038","journal-title":"J Neuropathol Exp Neurol"},{"key":"4272_CR48","unstructured":"Mawrin C et al (n.d.) WHO classification of tumors of the central nervous system"},{"key":"4272_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jnen\/nlv006","volume":"75","author":"RA Vaubel","year":"2016","unstructured":"Vaubel RA, Chen SG, Raleigh DR et al (2016) Meningiomas with rhabdoid features lacking other histologic features of malignancy: a study of 44 cases and review of the literature. J Neuropathol Exp Neurol 75:44\u201352. https:\/\/doi.org\/10.1093\/jnen\/nlv006","journal-title":"J Neuropathol Exp Neurol"},{"key":"4272_CR50","doi-asserted-by":"publisher","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","volume":"284","author":"YJ Machida","year":"2009","unstructured":"Machida YJ, Machida Y, Vashisht AA et al (2009) The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 284:34179\u201334188. https:\/\/doi.org\/10.1074\/jbc.M109.046755","journal-title":"J Biol Chem"},{"key":"4272_CR51","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Santagata S (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro-Oncology 19:1447\u20131456. https:\/\/doi.org\/10.1093\/neuonc\/nox094","journal-title":"Neuro-Oncology"},{"key":"4272_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/now235","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology 19:535\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/now235","journal-title":"Neuro-Oncology"},{"key":"4272_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","unstructured":"Pe\u00f1a-Llopis S, Vega-Rub\u00edn-de-Celis S, Liao A et al (2012) BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44:751\u2013759. https:\/\/doi.org\/10.1038\/ng.2323","journal-title":"Nat Genet"},{"key":"4272_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD et al (2016) Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet 48:407\u2013416. https:\/\/doi.org\/10.1038\/ng.3520","journal-title":"Nat Genet"},{"key":"4272_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","volume":"369","author":"M Cheung","year":"2015","unstructured":"Cheung M, Kadariya Y, Talarchek J et al (2015) Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene\u2013environment interaction. Cancer Lett 369:261\u2013265. https:\/\/doi.org\/10.1016\/j.canlet.2015.09.011","journal-title":"Cancer Lett"},{"key":"4272_CR56","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, Hoffman SE, Tavakol S et al (2022) A molecularly integrated grade for meningioma. Neuro-Oncology 24:796\u2013808. https:\/\/doi.org\/10.1093\/neuonc\/noab213","journal-title":"Neuro-Oncology"},{"key":"4272_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"key":"4272_CR58","doi-asserted-by":"publisher","first-page":"846232","DOI":"10.3389\/fonc.2022.846232","volume":"12","author":"AM Roehrkasse","year":"2022","unstructured":"Roehrkasse AM, Peterson JEG, Fung K-M et al (2022) The discrepancy between standard histologic WHO grading of meningioma and molecular profile: a single institution series. Front Oncol 12:846232. https:\/\/doi.org\/10.3389\/fonc.2022.846232","journal-title":"Front Oncol"},{"key":"4272_CR59","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/mc.20413","volume":"47","author":"Y Wei","year":"2008","unstructured":"Wei Y, Xia W, Zhang Z et al (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47:701\u2013706. https:\/\/doi.org\/10.1002\/mc.20413","journal-title":"Mol Carcinog"},{"key":"4272_CR60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955\u2013963. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol"},{"key":"4272_CR61","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F, Mamatjan Y, Suppiah S et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology 21:901\u2013910. https:\/\/doi.org\/10.1093\/neuonc\/noz061","journal-title":"Neuro-Oncology"},{"key":"4272_CR62","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04272-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:13:09Z","timestamp":1683529989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04272-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04272-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JM: Consultant, BK Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}